Product Image

Huperzine A 200 mcg

Source Naturals
4.6
★ ★ ★ ★ ★
(1397 ratings)
Huperzine 200 mcg
Product Image
Score84
Clear source and active-dose disclosure make this a well-defined Huperzine A tablet. Its potent serving and missing cycling guidance favor cautious, targeted use.
How scoring works
Quantity:120 Tablet(s) • (120 servings)
Goals:
Brain Health
Cognitive Support
Mental Focus
Productivity Boost

Score 84

Clear source and active-dose disclosure make this a well-defined Huperzine A tablet. Its potent serving and missing cycling guidance favor cautious, targeted use.
How scoring works
$25.89($0.21 per serving)
iHerb
$ 25.89
Pure Formulas
$ 25.89
Vitacost
$ 25.89
Report prices

Analysis

Huperzine A may support attention and memory by slowing acetylcholine breakdown. The 200 mcg amount and Huperzia serrata whole-plant source are both clearly disclosed.

The focused tablet is easy to assess, but it covers only one cognitive pathway. It does not supply broader support for mental energy, stress resilience, circulation, or neuronal structure.

The amount is at the upper end of common supplemental use and may be less flexible for sensitive users. No cycling guidance is provided, even though frequent use can allow cholinergic effects to accumulate.

Who is it for
  • Users seeking clearly sourced Huperzine A
  • Experienced users focused on short-term cognitive support
Best for
  • Transparent Huperzia serrata sourcing
  • Precise upper-range active delivery

Pros

  • Names the Huperzia serrata source
  • States the exact 200 mcg active amount
  • Focused formula avoids unrelated actives

Cons

  • Upper-range serving limits flexibility
  • No cycling guidance is supplied
  • Does not provide broad brain-nutrition support

Warnings

  • Huperzine A may cause nausea, dizziness, vivid dreams, muscle twitching, or a slowed heart rate.
  • Frequent dosing can allow cholinergic effects to build because Huperzine A remains active for an extended period.
  • Combining it with acetylcholinesterase inhibitors or other cholinergic medicines may intensify their effects.

Nutrient quality

88 Highest impact

A precise huperzine A amount from a named botanical source supports strong form quality. The upper-range amount and missing cycling guidance reduce suitability for continuous use.

.

Ingredient transparency

83 Highest impact

The active amount and botanical source are disclosed without a hidden blend. Cycling guidance, complete directions, and inactive ingredients are not supplied.

.

Customer satisfaction

69 High impact

The supplied average rating is strong. A very large rating base makes the average dependable, but no detailed experience evidence was supplied.

.

Value for money

95 Highest impact

Serving economics are highly favorable. Formula quality supports the asking price well.

.
Report analysis

Goals

Brain Health
Impact
Highest effect
A- Goal FitA+ Strength of SupportC+ CoverageA Formula Quality
Huperzine · 200 mcg

Huperzine A at 200 mcg directly supports acetylcholine signaling by slowing its breakdown. Human evidence supports cognitive effects, although it is stronger in impaired populations than in healthy users.

The amount and plant-extract source are fully disclosed in a streamlined tablet. Huperzine A may cause nausea, slowed heart rate, muscle twitching, or vivid dreams and can interact with other cholinergic medicines.

Study evidence
Huperzine Supportive 17 studies
Cognitive Support
Impact
Highest effect
A- Goal FitA+ Strength of SupportC+ CoverageA Formula Quality
Huperzine · 200 mcg

Huperzine A at 200 mcg directly supports acetylcholine signaling by slowing its breakdown. Human evidence supports cognitive effects, although it is stronger in impaired populations than in healthy users.

The amount and plant-extract source are fully disclosed in a streamlined tablet. Huperzine A may cause nausea, slowed heart rate, muscle twitching, or vivid dreams and can interact with other cholinergic medicines.

Study evidence
Huperzine Supportive 22 studies
Mental Focus
Impact
Highest effect
B+ Goal FitA+ Strength of SupportC+ CoverageA+ Formula Quality
Huperzine · 200 mcg

Huperzine A directly raises acetylcholine signaling and may sharpen attention or memory in selected situations. The 200 mcg amount is within a targeted range, but evidence in healthy adults is narrower than its strong mechanism suggests.

The source and exact active amount are clearly disclosed in a precise tablet. Its long half-life can allow cholinergic effects such as nausea, vivid dreams, slow heart rate, or muscle twitching to build with frequent use.

Study evidence
Huperzine Not classified

No linked studies yet.

Productivity Boost
Impact
High effect
B Goal FitA+ Strength of SupportD+ CoverageA- Formula Quality
Huperzine · 200 mcg

Huperzine A directly affects acetylcholine signaling and may support attention or memory. The precise microgram amount and plant source are clearly disclosed.

Evidence for routine productivity use in healthy adults is limited, and the formula covers only one pathway. The long-acting 200 mcg amount lacks cycling guidance and may increase nausea, dizziness, slowed heart rate, or other cholinergic effects with frequent use.

Study evidence
Huperzine No effect 1 study

Ingredients

IngredientAmount per serving
Huperzine A (Huperzia serrata whole plant extract)
200 mcg
Gluten Free Adults 18–50 Dairy Free Sugar Free Women Vegetarian
Report overview
A+ Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyA+ Value

The 200 mcg Huperzine A dose from Huperzia serrata fits the targeted range, and the tablet supports precise delivery of this small amount. The exact active dose and source are clear, but no cycling guidance is supplied. Cost efficiency is strong, although continuous daily use without breaks may increase cholinergic effects because Huperzine A has a long half-life.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. A phase II trial of huperzine A in mild to moderate Alzheimer disease.
    Rafii MS; Walsh S; Little JT; Behan K; Reynolds B; Ward C; Jin S; Thomas R; Aisen PS; Alzheimer's Disease Cooperative Study · Neurology · 2011
    Randomized trial210 participantsCognitive Support forHuperzine
  2. Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial.
    Wessinger CM; Inman CL; Weinstock J; Weiss EP · International journal of exercise science · 2025
    Randomized trial15 participantsBrain Health Productivity Boost forHuperzine
  3. Huperzine A for vascular dementia.
    Hao Z; Liu M; Liu Z; Lv D · The Cochrane database of systematic reviews · 2009
    Systematic review14 participants1 studies pooledCognitive Support forHuperzine
  4. Pharmacotherapy for Vascular Cognitive Impairment.
    Farooq MU; Min J; Goshgarian C; Gorelick PB · CNS drugs · 2018
    Narrative reviewBrain Health forHuperzine
  5. Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
    Xing SH; Zhu CX; Zhang R; An L · Evidence-based complementary and alternative medicine : eCAM · 2014
    Meta-analysis825 participants10 studies pooledBrain Health Cognitive Support forHuperzine
  6. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
    Zheng W; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Sun F; D'Arcy C; Meng X; Xiang YT · Human psychopharmacology · 2017
    Meta-analysis1,117 participants12 studies pooledCognitive Support forHuperzine
  7. Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
    Zhang Z; Shen Y; Li J; Tang Y; Zhou P; Ying T; Mo R; Ru Z; Zhao G; Zhu J; Li S; Zhao H · International journal of surgery (London, England) · 2026
    Randomized trial123 participantsCognitive Support Brain Health forHuperzine
  8. Treatment with Huperzine A improves cognition in vascular dementia patients.
    Xu ZQ; Liang XM; Juan-Wu; Zhang YF; Zhu CX; Jiang XJ · Cell biochemistry and biophysics · 2012
    Randomized trial78 participantsBrain Health forHuperzine
  9. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
    Zhang Z; Wang X; Chen Q; Shu L; Wang J; Shan G · Zhonghua yi xue za zhi · 2002
    Randomized trial202 participantsBrain Health Cognitive Support forHuperzine
  10. [Efficacy and safety of huperzine A in treating patients with mild cognitive impairment: a systematic review and Meta-analysis].
    Huang P; Li B; Guo YH; Feng S; Hu J; Liu QQ · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2019
    Meta-analysis9 studies pooledBrain Health forHuperzine
  11. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis.
    Wang BS; Wang H; Wei ZH; Song YY; Zhang L; Chen HZ · Journal of neural transmission (Vienna, Austria : 1996) · 2009
    Meta-analysis4 studies pooledCognitive Support forHuperzine
  12. Huperzine A for Alzheimer's disease.
    Li J; Wu HM; Zhou RL; Liu GJ; Dong BR · The Cochrane database of systematic reviews · 2008
    Meta-analysis454 participants6 studies pooledCognitive Support forHuperzine
  13. Huperzine A for the treatment of cognitive, mood, and functional deficits after moderate and severe TBI (HUP-TBI): results of a Phase II randomized controlled pilot study: implications for understanding the placebo effect.
    Zafonte RD; Fregni F; Bergin MJG; Goldstein R; Boudreau N; Monge I; Luz M; Frazier J; Giacino JT · Brain injury · 2021
    Randomized trialBrain Health forHuperzine
  14. The effects of Huperzine A on dementia and mild cognitive impairment: An overview of systematic reviews.
    Ghassab-Abdollahi N; Mobasseri K; Dehghani Ahmadabad A; Nadrian H; Mirghafourvand M · Phytotherapy research : PTR · 2021
    Systematic review6 studies pooledBrain Health forHuperzine
  15. The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis.
    Perng CH; Chang YC; Tzang RF · Psychopharmacology · 2019
    Meta-analysis44,854 participants235 studies pooledCognitive Support forHuperzine
  16. Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
    Gul A; Bakht J; Mehmood F · Journal of the Chinese Medical Association : JCMA · 2019
    Randomized trial100 participantsBrain Health forHuperzine
  17. The effect of anti-dementia drugs on Alzheimer disease-induced cognitive impairment: A network meta-analysis.
    Cui CC; Sun Y; Wang XY; Zhang Y; Xing Y · Medicine · 2019
    Meta-analysis33 studies pooledCognitive Support forHuperzine
  18. [Drug evaluation of huperzine A in the treatment of senile memory disorders].
    Zhang RW; Tang XC; Han YY; Sang GW; Zhang YD; Ma YX; Zhang CL; Yang RM · Zhongguo yao li xue bao = Acta pharmacologica Sinica · 1992
    Randomized trial56 participantsCognitive Support forHuperzine